UPDATE 1-FDA rejects Watson/Columbia premature birth drug
February 27, 2012 at 08:26 AM EST
Feb 27 (Reuters) - U.S. health regulators have rejected a vaginal gel from Watson Pharmaceuticals and Columbia Laboratories aimed at reducing the risk of premature birth, the companies said on Monday.
